To rule out the possibility that the differential sensitivity was derived from different genetic backgrounds of breast cancer cell lines, we asked whether overexpressing the GATA3 p.D335Gfs mutation in GATA3-wild-type cells would induce hypersensitivity against MDM2 inhibition (Supplementary Fig. 2h). The gene discussed is MDM2; the disease is breast cancer.